£75.00

Multiple Sclerosis: Practical Comprehensive Essentials

Price data checked 3 days ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£75 today · previous high £75 · all-time low £51

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 88 days • 88 data points

Historical
Generating forecast...
£75.00 £48.75 £54.48 £60.21 £65.93 £71.66 £77.39 13 March 2026 03 April 2026 25 April 2026 17 May 2026 08 June 2026

Price Distribution

Price distribution over 88 days • 2 price levels

Days at Price
Current Price
86 days 2 days · current 0 22 43 65 86 £51 £75 Days at Price

Price Analysis

Most common price: £51 (86 days, 97.7%)

Price range: £51 - £75

Price levels: 2 different prices over 88 days

Description

Multiple sclerosis (MS) is a progressive neurological disease that affects millions of people worldwide. Currently, the causes of MS are still unclear and the cure remains symptomatic, while the effectiveness of treatment varies widely among individuals. The clinical features and neurological defects derived from this progressive neurological disease are diverse since MS may affect the human central nervous system (CNS)) at all levels from the brain to the end of the spinal cord. Immunopathogenesis of MS involves many steps, including activation of peripheral leucocytes against putative CNS antigens, activated leucocytes with inflamed cerebral endothelial cells, the migration of activated lymphocytes and macrophages through the endothelium to the CNS environment, and further propagation of a massive immune response within the CNS. Such large-scale immune activation leads to loss of the myelin-oligodendrocyte complex. Various types of immune cells and mediators of the immune-inflammatory response actively contribute to MS pathogenesis. Genetic factors are also thought to play a central role in the development of most forms of MS. Axonal degeneration and neuronal loss are the core components of irreversible and permanent CNS atrophy and disability in MS. This book provides a comprehensive overview of the current MS situation as researchers try to understand the process and develop treatments that can slow or stop the disease, possibly repair the damage, alleviate specified symptoms, and improve the abilities of MS patients to function in everyday life. Various biological holistic approaches have been shown to slow disease progression in some patients, and the recovery rate of cellular mechanisms in the brain and spinal cord has been accelerated, increasing the possibility of achieving complete balance of the disease state. The panel reviews the background, focusing on novel strategies that are most likely to understand the biological mechanisms of recovery and translate findings into alternative comprehensive approach to the MS management. The modality of such complementary therapies adds a new dimension, geared to further improvement in the management and sustain the acquired long-term results of MS. This book will be necessary to researchers, research funders, healthcare advocates of MS research and treatment, and interested patients and their families.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
28 June 2022
Listed Since
28 October 2021

Barcode

No barcode data available

Similar Products You Might Like

Multiple Sclerosis Immunology: A Foundation for Current and Future Treatments
87% match

Multiple Sclerosis Immunology: A Foundation for Current and Future Treatments

Springer

£81.58 25 May 2026
Molecular Basis of Multiple Sclerosis: The Immune System: 51 (Results and Problems in Cell Differentiation, 51)
86% match

Molecular Basis of Multiple Sclerosis: The Immune System: 51 (Results and Problems in Cell Differentiation, 51)

Springer

£142.27 04 Jun 2026
Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis (Topics in Neuroscience)
86% match

Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis (Topics in Neuroscience)

Springer

£77.10 25 May 2026
Multiple Sclerosis: Diagnosis and Therapy
85% match

Multiple Sclerosis: Diagnosis and Therapy

Wiley-Blackwell

£72.62 14 May 2026
Multiple Sclerosis: Bench to Bedside: Global Perspectives on a Silent Killer: 958 (Advances in Experimental Medicine and Biology, 958)
85% match

Multiple Sclerosis: Bench to Bedside: Global Perspectives on a Silent Killer: 958 (Advances in Experimental Medicine and Biology, 958)

Springer

£109.24 10 Jun 2026
Molecular Biology of Multiple Sclerosis
84% match

Molecular Biology of Multiple Sclerosis

Wiley-Blackwell

£135.00 16 May 2026
Neurodegeneration in Multiple Sclerosis (Topics in Neuroscience)
82% match

Neurodegeneration in Multiple Sclerosis (Topics in Neuroscience)

Springer

£107.98 18 May 2026
82% match

Immunotherapies for Neurological Disorders: Unlocking the Brain's Defenses

Academic Press

£137.99 20 May 2026
From Basic Immunology to Immune-Mediated Demyelination (Topics in Neuroscience)
81% match

From Basic Immunology to Immune-Mediated Demyelination (Topics in Neuroscience)

Springer

£142.46 19 May 2026
Multiple System Atrophy
80% match

Multiple System Atrophy

Springer

£80.23 24 May 2026
MRI Atlas of MS Lesions
80% match

MRI Atlas of MS Lesions

Springer

£80.64 10 Jun 2026
Neural and Neuroendocrine Mechanisms in Host Defense and Autoimmunity
80% match

Neural and Neuroendocrine Mechanisms in Host Defense and Autoimmunity

Springer

£107.98 31 May 2026
79% match

Building Blocks of Neuroimmunometabolism: From Molecular Pathways to Therapeutic Strategies

Academic Press

£157.99 20 May 2026
Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)
79% match

Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)

Springer

£106.91 29 May 2026
Neurodegenerative Disorders: A Clinical Guide
79% match

Neurodegenerative Disorders: A Clinical Guide

Springer

£60.42 26 May 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
79% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£111.83 26 May 2026
Multiple Sclerosis: The Progressive Demyelinating Autoimmune Disease
79% match

Multiple Sclerosis: The Progressive Demyelinating Autoimmune Disease

Tellwell Talent

£45.00 11 May 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
79% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£108.75 09 Jun 2026
Multiple Sclerosis: Perspectives, Clinical Aspects & Cognitive Challenges (Neurology - Laboratory and Clinical Research Developments)
78% match

Multiple Sclerosis: Perspectives, Clinical Aspects & Cognitive Challenges (Neurology - Laboratory and Clinical Research Developments)

£152.99 07 Jun 2026
Schwann Cell Development and Pathology
78% match

Schwann Cell Development and Pathology

Springer

£80.64 26 May 2026
Stem Cell-based Therapy for Neurodegenerative Diseases: 1266 (Advances in Experimental Medicine and Biology, 1266)
78% match

Stem Cell-based Therapy for Neurodegenerative Diseases: 1266 (Advances in Experimental Medicine and Biology, 1266)

Springer

£71.18 05 Jun 2026
Diseases of the Spinal Cord: Novel Imaging, Diagnosis and Treatment
78% match

Diseases of the Spinal Cord: Novel Imaging, Diagnosis and Treatment

Springer

£99.46 30 May 2026
Central Nervous System Diseases and Inflammation
78% match

Central Nervous System Diseases and Inflammation

Springer

£107.98 20 May 2026
Multiple Sclerosis and Associated Demyelinating Disorders, An Issue of Neuroimaging Clinics of North America: Volume 34-3 (The Clinics: Radiology, Volume 34-3)
78% match

Multiple Sclerosis and Associated Demyelinating Disorders, An Issue of Neuroimaging Clinics of North America: Volume 34-3 (The Clinics: Radiology, Volume 34-3)

Elsevier

£65.96 25 May 2026